Drawing for RADR

USPTO serial 88612462

RADR

Reviewed by CopyMark Law Group

Reg. 5967658Status 702Registered
Filing date
Status date
Registration date
Jan 21, 2020
Examiner
HERRERA-MARCUS, ROSELLE MORALDE
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with RADR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nigamnarayan Acharya

Nigamnarayan Acharya Lantern Pharma Inc.1920 McKinney Avenue, 7th FloorDallas, TX 75201United States

Goods and services

ClassDescriptionStatusFirst use
042drug discovery services; pharmaceutical research and development services in the field of oncology; pharmaceutical drug discovery services in the field of oncology; scientific and medical research and development for pharmaceuticals, pharmaceutical preparations and substances in the field of oncologyACTIVEJan 1, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 13, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Apr 13, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Apr 13, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 20, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Jan 21, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 15, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 15, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 15, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 15, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 15, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 20, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 21, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 5, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 5, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 16, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 27, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 26, 2019DOCKASSIGNED TO EXAMINER—
Sep 24, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 14, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance